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Objectives This paper sought to report the outcomes of patients who are considered unfit for urgent surgical repair of as-
cending aortic dissections (AADs) who were treated using a novel endovascular repair strategy.
Background AAD is best treated by direct surgical repair. Patients who are unable to undergo this form of treatment have
poor prognoses. Previously, clinical case reports related to endovascular repair of AAD have been controversial.
Methods Between May 2009 and January 2011, 41 consecutive patients with AAD were treated in our institution. Fifteen
patients were considered poor candidates for direct surgical repair and subsequently underwent the endovascu-
lar repair.
Results The nature of the referral process to our tertiary care facility made the median time from aortic dissection onset
to treatment 25.5 days (range: 6 to 353 days). Dissections in 5 patients (33.3%) were considered acute, and
those in 10 patients (66.7%) were considered chronic. The rate of successful stent-graft deployment was 100%,
and there were no major morbidities or deaths in the perioperative period. Median follow-up was 26 months
(range: 16 to 35 months). One new dissection occurred in the aortic arch at 3 months and was treated with a
branched endograft. Significant enlargements of true lumens and decreases of false lumens and overall thoracic
aorta were noted after the procedures.
Conclusions Endovascular repair of AAD was an appropriate treatment option in patients who were considered poor candi-
dates for traditional direct surgical repair by the clinical criteria used in our institution. A larger series of
cases with longer follow-up is needed to substantiate these results. (J Am Coll Cardiol 2013;61:1917–24)
© 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.994Z
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iStanford type A aortic dissection is the most common form
of thoracic aortic dissection, accounting for approximately
60% of all cases. Untreated, this condition has a high
mortality, which emphasizes the need for emergency repair.
Classic therapy is direct surgical replacement of the ascend-
ing aorta with a prosthetic graft and maybe combined aortic
valve replacement, reconstruction of the aortic arch and its
branches, or both, as clinically indicated. Morbidity and
mortality for direct surgical repair both have improved
substantially in recent years (1,2). Unfortunately, the Inter-
national Registry of Acute Aortic Dissection showed that
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accepted August 30, 2012.approximately 28% of patients with acute type A aortic
dissections were considered unfit for open surgery and
received only medical management (3). Survival of these
medically managed patients is compromised significantly in
both acute and chronic circumstances compared with those
who receive direct surgical repair (4).
Recent improvements in endograft technology raised the
consideration that these new shorter, larger-diameter en-
dografts may be useful as a novel endovascular treatment for
patients with acute ascending aortic dissection (AAD) who
were considered poor candidates for direct surgical repair (5).
impfer et al. (6) conducted an ex vivo study demonstrating
hat stent-graft placement for AAD was feasible and could
chieve complete exclusion of the false lumen. Isolated case
eports describing endovascular repair of AAD have been
ublished, but patient follow-up was extremely limited (7–9).
ome of these reports identified major complications, includ-
ng procedural-related cerebral ischemia and progressive aortic
alvular insufficiency, and therefore raised serious questions
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Stent Grafting for Ascending Aortic Dissection May 7, 2013:1917–24regarding the value of endovascu-
lar repair of AAD (10). On the
basis of our previous experience
with endovascular repair of aortic
dissections, we combined newly
designed stent grafts with our en-
dovascular techniques for manag-
ing aortic dissection to offer treat-
ment to a select group of patients
with AAD (11–15).
Methods
Pre-operative evaluation. Between May 2009 and January
2011, 41 consecutive patients with AADs verified by com-
puted tomography angiography (CTA) were treated at our
institution, Changhai Hospital, Second Military Medical
University, Shanghai, China. All patients initially were
treated at other hospitals using aggressive medical manage-
ment and were referred to our hospital for further treatment.
The indications for referral usually were refractory hyper-
tension; persistent or recurrent chest pain, back pain, or
both; or progressive aneurysmal dilatation of the aorta
(increased more than 5 mm per 6 months or more than 10
mm per year). A consultation board, consisting of vascular
surgeons, cardiac surgeons, cardiologists, and anesthetists,
reviewed all cases. Most patients were offered direct surgical
repair for their AAD. Those patients who were judged poor
candidates for direct surgical repair were offered an endo-
vascular repair following the technique described in this
paper. It should be noted that most patients with acute
aortic dissection in China, as in other parts of the world,
usually receive emergency direct surgical repair for the
dissection with ascending aortic resection, prosthetic graft
reconstruction, and management of aortic valvular issues
and aortic arch pathological features, as indicated. The
patients described in this paper represent those who were
treated medically for their acute AAD for a variety of
reasons specific to the hospital where they initially sought
treatment. These patients were referred because of persis-
tent symptoms or anatomic findings that were thought to
require therapeutic intervention. These are patients who
survived the initial phase of acute aortic dissection with
medical therapy alone. The exclusion criteria for open
surgery used by our consultation board were established as
follows: advanced age (70 years), American Society of
Anesthesiologists classification of IV or more, New York
Heart Association classification (1994) of cardiac function
of III or C or more, or dysfunction of other important organ
systems (i.e., severe chronic obstructive pulmonary disease
or renal or hepatic insufficiency) (16,17).
Patients unfit for direct surgical repair were offered an
endovascular treatment using our novel technique if they
had suitable anatomic features. Those patients considered
unfit for endovascular repair were defined as follows: length
Abbreviations
and Acronyms
AAD  ascending aortic
dissection
CTA  computed
tomography angiography
LV  left
ventricle/ventricularof proximal or distal aortic landing zone 20 mm, involve- sment of coronary artery orifice, evidence of acute myocardial
infarction, severe aortic regurgitation (grade 3 or 4) docu-
mented by echocardiography, history of potentially life-
threatening ventricular arrhythmia, severe tortuosity or nar-
rowing of the descending aorta, or connective tissue
disorders (Marfan’s or Ehlers Danlos syndrome). Patients
with intramural hematoma or penetrating aortic ulcers were
excluded from this study. In all, 15 patients with AADs
were treated using our endovascular technique. The other
26 patients were treated either by direct surgical repair (n 
1) or continued best medical therapy (n  5). The
ndovascular procedure used in this study was approved by
ur internal review board, and appropriate informed consent
as obtained for each patient.
CTA was used to evaluate the entire aorta and iliac
rteries, and 3-dimensional reconstruction was obtained
sing Aquarius (TeraRecon, Foster City San Mateo, Cali-
ornia). Status of patency or thrombosis of the false lumen
as assessed using delayed phase imaging. Echocardiogra-
hy was used to evaluate cardiac myocardial and valvular
unction.
election of endovascular prosthesis. The size and length
f the stent grafts used in each case were determined by
nformation derived from the CTA and intraoperative
ortography with calibrated catheters. Zenith TX2 Pro-
orm endografts (Cook, Bloomington, Indiana) were used
n the ascending aorta.
ndovascular procedure. General anesthesia was used in
ll cases. Routine aortography of the ascending aorta from
he sinus of Valsalva was used to localize the proximal aortic
ear, the orifice of the coronary arteries, and the branches of
he aortic arch. A temporary bipolar pacemaker device
Medtronic, Minneapolis, Minnesota) was placed in the
ight ventricle from the right femoral vein. The cardiac
acing threshold was fewer than 60 beats/min. A defibril-
ator was available immediately for use as required. The
ook endograft was positioned in the ascending aorta
ver an extra-stiff guidewire (Cook). A pigtail catheter
OptiMed, Ettlingen, Germany) was positioned in the
scending aorta close to the aortic valve. In all cases, it was
ecessary for the endograft to be placed in the very proximal
scending aorta just distal to the orifices of the coronary
rteries. The design of the Cook TX2 system uses a long
apered nose cone as part of the delivery system. This nose
one had to be passed through the aortic valve and into the
eft ventricle (LV) to position the endograft at the appro-
riate deployment location. Initially, we planned to use
apid cardiac pacing to diminish cardiac output and blood
ressure to facilitate accurate endograft deployment. How-
ver, when the nose cone of the deployment system con-
acted the LV wall, ventricular tachycardia was induced in
very patient, resulting in significant hypotension. The
ndograft was deployed rapidly and, after the delivery
ystem was withdrawn from the ventricle, ventricular tachy-
ardia or fibrillation resolved in most cases within 30
econds. If it did not, chemical and/or electrical cardio-
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May 7, 2013:1917–24 Stent Grafting for Ascending Aortic Dissectionversion using the defibrillator was accomplished. Arte-
riographic visualization of the aorta from the root to the
distal aortic arch was obtained to verify patency of the
coronary and brachiocephalic arteries and to show suc-
cessful entry tear exclusion. Complete details of the
remaining portion of the procedure, including removal of
the delivery system and repair of femoral access, have
been described previously (18).
Follow-up. Overall aortic and true lumen diameters were
measured at the level of the sinotubular junction, the ostium
of the innominate artery, the point of maximum ascending
aortic diameter, and the ostium of the left subclavian artery.
Three-dimensional TeraRecon reconstructions were used
for these measurements and were obtained at 6 months after
the procedure and annually thereafter. Additional CTA
examinations were obtained if patients demonstrated new
symptoms or signs of adverse events. All measurements
were made by the first author and were verified indepen-
dently by the coauthor.
Statistical analysis. Continuous variables were reported as
mean  SD. Skewed variables were summarized as median
nd range. SPSS software version 13.0 (SPSS, Inc., Chi-
ago, Illinois) was used for all analyses. The comparisons of
iameters were drawn by 2-sided paired sample t tests. A
value of p  0.05 was considered significant.
Results
The demographics of patients who underwent endovascular
procedures are presented in Table 1. The mean age of
patients was 65.0  12.1 years (range: 45 to 78 years). The
median time from onset of acute dissection to repair was
Patient Characteristics and Clinical OutcomesTable 1 Patient Characteristics and Clinical Outcomes
Sex (male) 12 80% (12/15)
Age (yrs) 65.0 12.1
Risk of open surgery
Advanced age 7 38.9% (7/18)
Severe COPD 3 16.7% (3/18)
Cardiac dysfunction 2 11.1% (2/18)
Renal insufficiency 2 11.1% (2/18)
Others* 4 22.2% (4/18)
Dissection range
Confined to ascending aorta 1 6.7% (1/15)
Involving descending aorta 1 6.7% (1/15)
Involving abdominal aorta 13 86.7% (13/15)
ICU stay (days) 3.3 1.0
Hospitalization time (days) 9.4 2.5
In-hospital complication 2 (arrhythmia) 13.3% (2/15)
In-hospital mortality 0 0%
Follow-up time (median, range), months 22, 12–31 —
Follow-up complications 1 (new dissection) 6.7% (1/15)
Reintervention 1 6.7% (1/15)
Follow-up mortality 0 0%
Values are n, % (n/N), or mean  SD. *Others: 1 case with hepatic inadequacy (post-hepatitic
cirrhosis, Grade B of Child-Pugh Classification) and airway obstruction, 1 with prior thoracotomy,t
and 1 stroke.
COPD  chronic obstructive pulmonary disease; ICU  intensive care unit.25.5 days (range: 6 to 353 days). We consider the 14-day
period after onset of aortic dissection to be the acute phase.
After that period, the dissection was considered chronic.
Endovascular treatment was accomplished in 5 patients
(33.3%) in the acute phase and in 10 patients (66.7%) in the
chronic phase. Treatment delay was intrinsic to the hospital
referral system except in 1 patient treated at 353 days after
occurrence of the dissection because of progressive false
lumen enlargement. The false lumen in the ascending aorta
expanded by 12 mm, resulting in tracheal compression,
recurrent laryngeal nerve dysfunction, dyspnea, and hoarse-
ness. The endovascular repair was undertaken because of
these issues.
One patient required angioplasty and stenting at a referral
hospital 16 days after onset of the dissection because of false
lumen–induced compromised flow to the left renal artery
(Fig. 1). Two patients showed the proximal entry tears in
the ascending aorta to be excluded, but flow persisted in the
false lumen. This false lumen flow resulted from secondary
tears in the descending aorta with retrograde flow, and these
secondary tears were repaired using stent-graft coverage in
the descending thoracic aorta (Hercules 36-60 stent graft,
Microport, Shanghai, China, and Zenith TX2 36-197 stent
graft, Cook) (Fig. 2).
Mean endovascular procedure time was 128.6  26.2
min. The results of intraoperative measurement are re-
corded in Table 2. The mean ratio of the diameter of the
stent graft to that of the aorta (proximal to the tear) was
137.3  11.6%. Average stent-graft coverage of the ascend-
ing aorta was 84.1  9.3%.
One episode of ventricular tachycardia occurred during
guidewire placement in the LV, and this resolved with
guidewire repositioning. One patient experienced a su-
praventricular arrhythmia on the first post-operative day and
required chemical cardioversion for resolution. Length of
stay was 3.3  1.0 days, and the total hospital length of stay
as 9.4  2.5 days (Table 1).
Median follow-up was 26 months, ranging from 16 to 35
onths. A new dissection, secondary to an entry tear in the
rch, was noted by CTA 3 months after primary procedure.
his was treated successfully using a customized branched
tent graft. No other complications or deaths were recorded
n the follow-up period. Complete thrombosis of the false
umen of the ascending aorta was noted in all 15 patients.
omplete thrombosis of the false lumen of the descending
orta was noted in 10 patients (10 of 14, 71.4%), and partial
hrombosis was noted in 4 patients (4 of 14, 28.6%). No
eveloped aortic insufficiency was observed in the follow-up
eriod. The pre-operative LV end-systolic diameter was
7.9  10.3 mm, and the follow-up LV end-systolic
iameter was 41.3  4.2 mm (p  0.168). The LV ejection
raction was 54.6  2.8% before the procedure and 53.0 
.5% during the follow up (p  0.058).
The diameter of the sinotubular junction was not en-
arged after the procedure. The pre-operative diameter of
he sinotubular junction was 26.6  3.4 mm, and the
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Stent Grafting for Ascending Aortic Dissection May 7, 2013:1917–24follow-up diameter was 27.4  3.8 mm (p  0.068). Mean
maximal diameter of the ascending aorta significantly de-
creased from 56.88  6.7 mm before the stent grafting to
5.51 4.6 mm during follow-up (p 0.001). Further, the
iameter of distal ascending aorta significantly decreased
rom 46.5  11.3 mm to 41  11.7 mm (p  0.04). The
ean diameter of the proximal ascending aorta (50.8  5.9
Figure 1 Ascending Aortic Dissection with Compromised Branc
(A) Computed tomography angiography (CTA) image obtained before stent grafting
mised by the dissection (arrows). (B) Pre-operative aortography showing the aneu
ing that the entry tear was completely excluded. Comparison between (D) pre-ope
level of maximal ascending aorta showing that the diameter of ascending aorta sh
thrombosis of the false lumen along the ascending aorta and the patency of the c
Figure 2 Exclusion of the Tears in Ascending and Descending A
(A) After 36 days of medical treatment, the patient reported recurrent chest pain
the middle part of the ascending aorta and that the false lumen was patent. (B) C
(C) 24-month CTA image showing that the false lumen was completely thrombosem vs. 46.0  5.1 mm, p  0.214) and mean diameter of
he proximal descending aorta (39.2  3.0 mm vs. 36.5 
.4 mm, p 0.185) were not significantly different between
re-operative and post-operative follow-up measurements
Fig. 3A). True lumen diameter significantly increased
uring follow-up. Mean diameter increased from 22.21 
.8 mm to 36.37  6.1 mm at the level of maximal
ery
ng that the primary stent reopened the left renal artery, which had been compro-
l expansion of the ascending aortic dissection. (C) Completion aortography show-
CTA image and (E) CTA image obtained at the 24-month follow-up at the same
nd the true lumen expanded. (F) Follow-up CTA image confirming complete
y arteries and the supra-arch branch arteries.
in 1 Procedure
s referred to our institution. Immediate CTA revealed the entry tear located in
tion aortography confirming that the important branch arteries were patent and
reviation as in Figure 1.h Art
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May 7, 2013:1917–24 Stent Grafting for Ascending Aortic Dissectionascending aortic diameter (p 0.001), from 25.4 7.1 mm
to 33.3  5.5 mm at the level of the proximal ascending
aorta (p  0.003), from 32.7  4.4 mm to 36.3  3.4 mm
at the level of the distal ascending aorta (p  0.022), and
from 28.3  2.9 mm to 31.0  3.3 mm at the level of the
roximal descending aorta (p  0.011) (Fig. 3B). The
iameter of the false lumen at different levels significantly
ecreased in the follow-up phase: from 34.1  8.5 mm to
.6  6.2 mm at the level of the maximal ascending aorta
p  0.001), from 25.8  8.1 mm to 12.1  6.1 mm at the
level of proximal ascending aorta (p  0.001), from 13.6 
6.4 mm to 4.9  3.1 mm at the level of the distal ascending
aorta (p  0.001), and from 11.8  4.2 mm to 5.1  3.2
mm at the level of the proximal descending aorta (p 
0.001) (Fig. 3C). The results of patients treated by open
surgery or best medical therapy are presented in Table 3.
Discussion
Several risk models previously were reported that predict
surgical mortality for repair of type A aortic dissection.
Using these parameters, 10% to 30% of patients with AAD
were considered high risk for direct surgical repair and
received medical therapy (16,17). Mortality for medically
treated patients has been substantially higher than those
treated by direct surgical repair (4). One study showed that
thrombosed false lumen documented by transesophageal
echocardiography in type A aortic dissections is an indicator
for survival (19). This implies that closure of the dissection
entry tear and subsequent false lumen thrombosis should
improve long-term survival in these patients. Our results
show that when an endovascular repair induced false lumen
thrombosis, the maximum diameter of the ascending aorta
decreased and survival during the follow-up period oc-
curred. Sobocinski et al. (5) retrospectively reviewed the
CTA images of 102 cases of acute Stanford type A aortic
dissections who had undergone open repairs and concluded
that approximately half of the cases were potential candi-
Intraoperative Measurements and Stent-Graft ChoiceTable 2 Intraoperative Measurements and Stent-Graft Choice
Intraoperative measurements (mm)
Aortic diameter (proximal to the tear) 28.4 7.1
Aortic diameter (distal to the tear) 33.0 4.0
Length from STJ to IA 92.9 12.5
Length from STJ to tear 50.4 22.7
Length from tear to IA 92.9 12.5
Longitudinal length of tear 8.7 7.5
Stent-graft choice
Stent-graft diameter (mm) 39.0 3.5
Stent-graft length (mm) 78.9 2.0
Stent-graft diameter/proximal landing zone diameter (%) 137.3 11.6
Stent-graft diameter/distal landing zone diameter (%) 116.8 14.4
Stent-graft length/ascending aorta length (greater curvature, %) 84.1 9.3
Values are mean  SD.
IA  innominate artery; STJ  sinotubular junction.dates for endovascular repair.Endovascular repair of AAD was reported first in 2003
(8). At 1 year of follow-up, the patient evidenced cardio-
megaly, severe aortic valvular insufficiency, and impaired left
heart contractility documented by echocardiography. This
patient was converted to open repair, a Bentall operation, 21
months after the endovascular procedure (10). There have
been sporadic reports of other endovascular AAD repairs,
some of which describe significant risks for procedure-
related cerebral infarction, fatal arrhythmias, myocardial
Figure 3 Mean Diameters Before and
12 Months After Endovascular Procedure
Bar graphs showing the mean diameters of (A) the total aorta, (B) the true
lumen, and (C) the false lumen compared between pre-operative and 12-month
follow-up measurements. The asterisk indicates that the change was signifi-
cant (p  0.05). DAA  distal ascending aorta; MAA  maximal ascending aor-
ta; PAA  proximal ascending aorta; PDA  proximal descending aorta.
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Stent Grafting for Ascending Aortic Dissection May 7, 2013:1917–24infarctions, and cardiac perforation (7,9,10,20,21). In this
study, we found that aortic regurgitation could be stable
after the endografting for AAD. This may be related to the
stable diameter of the sinotubular junction and to the
positive hemodynamic change in the ascending aorta when
the true lumen was expanded in the follow-up period.
Endovascular repair for AAD certainly is not possible for
every patient. In an attempt to define which patients are best
suited for endovascular treatment, we divided the ascending
aorta into 3 sections. If the entry tear is located in the distal
third of the ascending aorta, a branched endograft or hybrid
or fenestration procedure is necessary to maintain perfusion
to the brachial cephalic vessels (22). Entry tears located
in the middle third of the ascending aorta are ideal cases
for tube stent-graft repair (7,23). Entry tears in the proximal
third of the ascending aorta do not offer a suitable proximal
landing zone for the endograft in most cases (21).
A variety of stent grafts have been reported as useful to
repair entry tears in the ascending thoracic aorta (e.g., the
46  100-mm Talent or Valor graft [Medtronic] and the
40  100-mm CTAG graft [W. L. Gore & Associates,
nc., Flagstaff, Arizona]) and a custom-made covered stent
f 46  85 mm (Jotec, Hechingen, Germany) (7,9,21).
ndografts for the ascending aorta must be of relatively
hort length (100 mm or less) and larger diameter (46 mm
iameter) (24). Metcalfe et al. (25) presented 1 case of
ndovascular repair of an acute AAD using an endovascular
tent graft manufactured specifically for the ascending aorta.
he endograft used has proximal and distal bare stent
xation. We do not recommend proximal bare stent con-
guration because these exposed metal fixation points could
njure the aortic valve and may compromise the ability to
chieve an appropriate proximal seal zone (18). Zenith TX2
xtension stent grafts (Cook), with a diameter varying from
2 to 42 mm and length ranging from 77 to 81 mm, were
sed in this study.
Several access sites for the delivery system used for
ndovascular ascending aortic repair have been suggested
26,27). Chuter (28) reported that the retrograde carotid
pproach often produced carotid obstruction from the
bstructor effect of the delivery system, and therefore
ncreased the risk of cerebral ischemia or infarction. He
referred a conduit attached to the distal innominate artery.
e believe that the flexibility of the current stent-graft
Outcomes of Open Surgeryand Medically Treated PatientsTable 3 Outcom s of Open Surgeryand Medically Treated Patients
Age (yrs) Phase* Outcome
Open surgery 59.3 3.2 16 acute 1 early death, 1 lung infection
and prolonged ICU stay
5 chronic 1 significant stroke
Medicine 67.5 7.2 1 acute Died
4 chronic 1 sudden death
*The acute or chronic phase refers to the time when the patients were referred to our hospital.
ICU  intensive care unit.elivery system allows the device to be passed across theaortic arch in most cases without difficulty. The retrograde
femoral route for device delivery is preferred for most cases.
When the external iliac or femoral arteries are small,
tortuous, or severely stenosed, common iliac or abdominal
aortic conduits may be required to introduce the delivery
system. Endograft deployment into the ascending aorta
retrograde from the apex of the LV also has been reported
to be similar to deployment of the Stentor version of the
prosthetic aortic valve (18).
The current design of the delivery systems for thoracic
aortic endografts offered by most manufacturers is less than
optimal for use in the ascending aorta. The long tapered
nose cone associated with these devices that facilitates
passage of the device through the iliac vasculature and
around the aortic arch often requires that this nose cone
traverse the aortic valve and enter the LV (8). In our series
of 15 patients, everyone had ventricular tachycardia when
the delivery system nose cone contacted the wall of the LV.
When the delivery system was withdrawn, either conversion
to normal rhythm occurred or the patient required chemical
or electrical cardioversion. We recommend that temporary
cardiac pacing and a defibrillator be readily available for use
if necessary during ascending thoracic aortic endografting.
At no other site in the aorta is precise deployment of an
endograft more important than when it is used in the
ascending thoracic aorta. Preservation of coronary artery
flow, aortic valve function, and perfusion of the branch
vessels of the aortic arch are critical to successful outcome of
these procedures. Elective adenosine-induced cardiac arrest
was introduced to decrease cardiac output and to maximize
accuracy of device deployment by avoiding systolic blowback
of the device during deployment (29). We did not use
temporary adenosine-induced arrest in our patients. We
planned to use temporary rapid ventricular pacing (heart
rate to 180 beats/min) to decrease blood pressure and
cardiac output. This technique has been described and used
by many authors as a means of insuring accurate deployment
of the endograft (7). In our patients, delivery system nose
cone contact with the LV wall-induced ventricular tachy-
cardia or fibrillation with resultant hypotension and de-
creased cardiac output so that we could deploy our endograft
accurately. Intraoperative use of intraoperative transesoph-
ageal echography has been recommended to assist with
precise endograft deployment, especially when the proximal
deployment location is very close to the coronary sinus (7,9).
There also have been successful cases reported without using
transesophageal echocardiography (8,21). The value of this
imaging method is related to the experience of the operator
and the quality of the imaging system.
In endovascular repair of an abdominal aortic aneurysm,
an endostapling system has been developed for treatment of
proximal graft migration and type I endoleak (30). To our
knowledge, this endostapling system has not been used in
the ascending aorta in humans.
Transcatheter aortic valve implantation has become the
standard of care under certain circumstances in many
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May 7, 2013:1917–24 Stent Grafting for Ascending Aortic Dissectioncountries. It is conceivable that combining this technology
with an endograft may make the possibility of treating
AADs associated with compromised aortic valve function a
reality (31). It should be noted that multidisciplinary heart
and aorta teams, including vascular surgeons, cardiac sur-
geons, and cardiologists, making the decisions of treatment
strategy and cooperating in the procedure are critical to give
the patients fittest treatment and to enhance the safety of
the endovascular procedure.
Study limitations. This study demonstrates experience
ith the endovascular repair of AADs in a small group of
atients. It also documents the aortic remolding after the
ndovascular repair. The limitations of this study are the
mall sample size (n  15) and the median follow-up of
only 26 months. Further study with a larger sample size and
longer follow-up are necessary before any significant con-
clusions can be reached regarding the effectiveness of this
form of treatment of AAD. Future studies should begin by
comparing the effectiveness of endovascular treatment of
AAD with that of best medical therapy. Only if the results
of endovascular repair prove durable will a trial comparing
this treatment method with direct surgical repair, the
current gold standard, be appropriate.
Conclusions
Our results of endovascular repair of AAD have given us an
optimistic view of this procedure. In patients who are
considered high risk for a potentially poor outcome related
to direct surgical repair of their AAD, an endovascular
approach may prove to be a very acceptable alternative
therapy. Design improvements for the delivery system,
especially with respect to the nose cone, will be a necessary
consideration for endograft devices planned for use in the
ascending aorta.
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